InvestorsHub Logo
Followers 24
Posts 1728
Boards Moderated 0
Alias Born 08/07/2022

Re: meds4life post# 442635

Thursday, 12/14/2023 12:30:18 PM

Thursday, December 14, 2023 12:30:18 PM

Post# of 462468
Is remylination being alleged? Or just fewer T1 and T2 lesions appearing per unit time? If the latter then there is a pathway to approval, but this biomarker has been shown (by Biogen itself, whose Avonex showed 98% reduction in lesions) not to actually correlate with disease progression.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News